This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

UnitedHealthcare unlikely to share innovation on 'equal footing' after acquiring Change Healthcare, DOJ expert testifies

By Khushita Vasant ( August 10, 2022, 00:28 GMT | Insight) -- UnitedHealthcare Group’s $13 billion proposed acquisition of Change Healthcare will not reduce innovation in the healthcare claims industry, but it is likely to hurt competition because UnitedHealth is unlikely to share innovations with rivals on an “equal footing,” an expert witness for the US Department of Justice said today.UnitedHealthcare Group’s $13 billion proposed acquisition of Change Healthcare will not reduce innovation in the healthcare claims industry, but it is likely to hurt competition because UnitedHealth is unlikely to share innovations with rivals on an “equal footing,” an expert witness for the US Department of Justice said today....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login